Cadonilimab in Locally Advanced MSI-H/dMMR Colorectal Cancer

NCT05815290 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

dMMR Colorectal Cancer

Interventions

DRUG: Cadonilimab

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences